Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for AirSculpt Technologies Inc. (AIRS:NASDAQ), powered by AI.
AirSculpt Technologies Inc. is currently trading at $3.32. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for AirSculpt Technologies Inc. on Alpha Lenz.
AirSculpt Technologies Inc.'s P/E ratio is -23.2.
“AirSculpt Technologies Inc. trades at a P/E of -23.2 (undervalued) with modest ROE of -10.1%. 3Y revenue CAGR of 10.6% highlights clear growth momentum.”
Ask for details →AirSculpt Technologies Inc. operates within the healthcare sector, specializing in advanced body contouring procedures. The company’s primary function is to offer minimally invasive laser liposuction services through its proprietary AirSculpt technology. This technique is designed to remove unwanted fat while minimizing patient discomfort and downtime, distinguishing it from traditional liposuction methods. AirSculpt Technologies Inc. caters to a variety of clients seeking aesthetic enhancements and body sculpting solutions, impacting the medical and personal care industries significantly. By providing a specialized service that blends healthcare and cosmetic enhancement, the company plays a pivotal role in the elective surgery market. Founded on clinical innovation and patient satisfaction, AirSculpt Technologies Inc. aims to lead advancements in cosmetic surgery by continuously refining their procedures for effectiveness and safety. This specialization not only underscores its market presence but also reflects broader trends towards non-invasive and outpatient-friendly medical treatments in the healthcare industry.
“AirSculpt Technologies Inc. trades at a P/E of -23.2 (undervalued) with modest ROE of -10.1%. 3Y revenue CAGR of 10.6% highlights clear growth momentum.”
Ask for details →AirSculpt Technologies Inc. (ticker: AIRS) is a company listed on NASDAQ in the Healthcare sector (Medical Care Facilities). It has approximately 389 employees. Market cap is $192M.
The current price is $3.32 with a P/E ratio of -23.21x and P/B of 2.42x.
ROE is -10.11% and operating margin is -1.00%. Annual revenue is $180M.